ISRCTN78428828已完成不适用
eonatal Insulin Replacement Therapy in Europe
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Birth weight <1500 g
- •2. Requiring intensive care and in whom it is considered appropriate to continue intensive care
- •3. Less than 24 hours of age
- •4. Written informed parental consent
排除标准
- •1. Maternal diabetes including gestational diabetes
- •2. Babies where the appropriateness of continuing intensive care is being discussed
- •3. Major congenital anomalies
研究者
相似试验
已完成
4 期
Safety and Efficacy of Insulin Aspart in Children With Type 1 DiabetesDiabetes Mellitus, Type 1DiabetesNCT01467141Novo Nordisk A/S26
进行中（未招募）
4 期
Insulin pump therapy for adolescents with type 1 diabetes and poor glycaemic controlMetabolic and Endocrine - DiabetesType 1 diabetesACTRN12614001198617Martin de Bock10
已完成
4 期
Initiation of Insulin Aspart in Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00572806Novo Nordisk A/S6
招募中
不适用
The effective switch from intensive insulin therapy to the once-daily human GLP-1 analogue liraglutide in patients with fairly well controlled type 2 diabetestype 2 diabetesJPRN-UMIN000005202Department of Diabetes and Endocrinology, Kanto Rosai Hospital20
进行中（未招募）
不适用
Pre-POINT (Primary Oral/intranasal INsulin Trial) study A dose finding safety and immune efficacy study for primary mucosal insulin therapy in islet autoantibody negative children at high genetic risk for type 1 diabetes - Pre-POINTpre-type 1 diabetes (islet autoimmunity in non-diabetic relatives of subjects with type 1 diabetes)EUCTR2005-001621-29-ATFaculty of Medicine Carl Gustav Carus, University of Technology, Dresden40